Anodyne

Primidone
Generated by the Chemistry Development Kit (http://github.com/cdk)
Salts
[]
Sodium
Generated by the Chemistry Development Kit (http://github.com/cdk)
Molecular structure via molpic based on CDK
[]
Conformer structure via JSmol
Physical properties
[]
218.25 g/mol [1]
AppearanceCrystals [1]
OdorOdorless [1]
TastePractically tasteless [1]
Melting point538 to 540 °F (NTP, 1992) [1]
DecompositionWhen heated to decomposition it emits toxic fumes of /nitrogen oxides/. [1]
Solubility>32.7 [ug/mL] (The mean of the results at pH 7.4) [1]
0.9 [1]
Structural Identifiers
[]
C12H14N2O2 [1]
5-ethyl-5-phenyl-1,3-diazinane-4,6-dione [1]
CCC1(C(=O)NCNC1=O)C2=CC=CC=C2 [1]
InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16) [1]
InChIKeyDQMZLTXERSFNPB-UHFFFAOYSA-N [1]
Dosing
[]
Elimination half-lifePrimidone: 5 – 18 h,Phenobarbital: 75 – 120 h,PEMA: 16 h[4]Time - reach steady state:Primidone: 2 – 3 days,Phenobarbital&PEMA 1 – 4weeks[5]

Primidone

Primidone (also known as Primaclone, Mysoline, Lepimidin, 2-Deoxyphenobarbital, Neurosyn, Liskantin, Lepsiral, Mylepsin, Mysedon or Primidon)

Chemistry

Salts []

Primidone is typically found in the form of its sodium salt.

 []

Primidone is a achiral mixture

Legal status []

  • Australia: Primidone is a S4 substance.
  • Brazil: Primidone is a C1 substance.[3]
  • Canada: Primidone is a prescription only substance.
  • United Kingdom: Primidone is a prescription only substance.
  • United States: Primidone is a prescription only substance.

See also []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 4909, Primidone. Accessed July 13, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/4909

  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Primidone. UNII: 13AFD7670Q. Global Substance Registration System. Accessed July 13, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/13AFD7670Q

  3. Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed July 13, 2025. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992

  4. CDER, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Primidone (Mysoline). Brain Injury Resource Foundation. Accessed July 13, 2025. http://www.birf.info/home/bi-tools/qlinks_anticon.html

  5. Yale Medical School, Department of Laboratory Medicine. Therapeutic Drug Levels. Yale Medical School. Accessed July 13, 2025. http://info.med.yale.edu/labmed/clinical/labman/D011.html